Dysfunctional Breathing in Post COVID-19 Condition.
DB-PCC
Dysfunctional Breathing in Patients With Post COVID-19 Condition
1 other identifier
observational
200
1 country
2
Brief Summary
The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition. The main question aims to answer which measurements can identify and asses dysfunctional breathing in patients with post COVID-19 condition? Participants for this study will be recruited from the ReCov cohort will be evaluated with diffrent measurments and questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2025
CompletedFirst Posted
Study publicly available on registry
January 15, 2025
CompletedStudy Start
First participant enrolled
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedFebruary 14, 2025
February 1, 2025
12 months
January 13, 2025
February 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breathing pattern by Respiratory Movement Measuring Instrument (RMMI) and Health-related Quality of Life (EQ-5D-5L)
Will be assesed in a supine position, using the RMMI. First, during 30 seconds of tidal volume breathing. Second, during 60 seconds of performing maximal breathing manoeuvres interspaced by tidal volume breathing and then during 60 seconds after performing activity that triggers dyspnea. The RMMI records bilateral changes in the anterior posterior diameter, including both upper and lower thoracic and abdominal movements. Health-related Quality of Life is measured with EuroQualityOf Life 5 dimensions questionnaire (EQ-5D-5L), which is an instrument that evaluates the generic quality of life. EQ-5D includes a descriptive system, which comprises 5 dimensions of health: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression. A descriptive index-score between 0-1, higher score indicates higher HRQoL. EQ-5D also includes a visual analog scale (VAS), which records self-rated health status on a graduated (0-100) scale, with higher scores for higher HRQoL
Assessment will be applied only once and takes about 5-10 minutes to be completed.
Secondary Outcomes (17)
Maximal Inspiratory Pressure (MIP)
Assessment will be applied only once and takes about 5-10 minutes to be completed.
Maximal Expiratory Pressure ( MEP)
Assessment will be applied only once and takes about 5-10 minutes to be completed.
Chest mobility
Assessment will be applied only once and takes about 5 minutes to be completed.
Six-minute walk test (6MWT)
Assessment will be applied only once and takes about 15 minutes to be completed.
Spirometry
Assessment will be applied only once and takes about 30 minutes to be completed.
- +12 more secondary outcomes
Study Arms (1)
Patients with post COVID-19 condition.
Patients with post COVID-19 condition and respiratory problems.
Eligibility Criteria
Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be \> 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing)
You may qualify if:
- Patients that state that they have persistent respiratory problems, have 2 or higher on mMRC scale or 23 and over on the Nijmegen scale will be included.
You may not qualify if:
- Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Karolinska University Hospitalcollaborator
Study Sites (2)
Karolinska University Hospital
Stockholm, Solna, 17176, Sweden
Karolinska Institutet
Huddinge, 14183, Sweden
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 13, 2025
First Posted
January 15, 2025
Study Start
January 15, 2025
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
February 14, 2025
Record last verified: 2025-02